Journal of Medical Screening

Papers
(The TQCC of Journal of Medical Screening is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
“DNA tests for every baby on the NHS”47
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening30
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review24
Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa23
Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health21
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms20
Risk stratification in medical screening19
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway–Impact on radiologist person-years, costs and effects18
Prediction model to prioritize colorectal cancer screening with visual colonoscopy17
Cell-free DNA screening for sex chromosome aneuploidy in 67,099 pregnancies: A retrospective analysis16
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality11
Timely adherence to follow-up after high-risk lung cancer screenings10
Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China9
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes9
Applying the healthcare failure mode and effects analysis approach to improve the quality of an organised colorectal cancer screening programme9
Percentage mammographic density or absolute breast density for risk stratification in breast screening: Possible implications for socioeconomic health disparity8
Equity challenges in bowel cancer screening: A decade of spoilt faecal immunochemical test kit data in New Zealand8
Universal newborn hearing screening in Malaysian public hospitals: A national evaluation of coverage, quality indicators, and outcomes (2022–2023)7
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing7
Thanks to reviewers7
Response to the letter: “Ethics of screening promotion: A slippery slope to forced marketing?”7
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study7
The Risk-Screening Converter: Use of multiple risk factors7
The Risk-Screening Converter6
Folic acid and neural tube defects: Discovery, debate and the need for policy change6
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines6
Effects of COVID-19 pandemic on breast cancer screening: A 6-year cohort study6
Cancer screening programs in Japan: Progress and challenges6
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India5
Trends in colorectal cancer screening in the United States, 2012 to 20205
Age at breast cancer screening in women with intellectual disability5
Cancer screening after the age of 75: Nationwide population-based trends5
Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening5
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study5
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis5
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada5
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening5
Comments on “Effects of COVID-19 pandemic on breast cancer screening” by Huang et al. https://doi.org/10.1177/096914132513384564
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis4
Colorectal cancer screening with faecal immunochemical test: Patterns of participation4
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test4
Response to ‘Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change’4
Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010–20194
Positive predictive value metrics for multicancer detection tests4
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue4
Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection de4
0.070425987243652